# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BTIG analyst David Larsen downgrades P3 Health Partners (NASDAQ:PIII) from Buy to Neutral.
P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of ...
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...
Lake Street analyst Brooks O'Neil maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from...